CBRE GROUP INC - A (CBRE) Fundamental Analysis & Valuation

NYSE:CBRE • US12504L1098

Current stock price

141.81 USD
-0.92 (-0.64%)
At close:
141.81 USD
0 (0%)
After Hours:

This CBRE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CBRE Profitability Analysis

1.1 Basic Checks

  • In the past year CBRE was profitable.
  • In the past year CBRE had a positive cash flow from operations.
  • Each year in the past 5 years CBRE has been profitable.
  • Each year in the past 5 years CBRE had a positive operating cash flow.
CBRE Yearly Net Income VS EBIT VS OCF VS FCFCBRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • With an excellent Return On Assets value of 3.75%, CBRE belongs to the best of the industry, outperforming 83.87% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 13.03%, CBRE belongs to the top of the industry, outperforming 93.55% of the companies in the same industry.
  • The Return On Invested Capital of CBRE (5.08%) is better than 77.42% of its industry peers.
  • CBRE had an Average Return On Invested Capital over the past 3 years of 6.32%. This is in line with the industry average of 5.31%.
Industry RankSector Rank
ROA 3.75%
ROE 13.03%
ROIC 5.08%
ROA(3y)4.03%
ROA(5y)5.45%
ROE(3y)12.16%
ROE(5y)15.19%
ROIC(3y)6.32%
ROIC(5y)7.21%
CBRE Yearly ROA, ROE, ROICCBRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • The Profit Margin of CBRE (2.85%) is better than 64.52% of its industry peers.
  • In the last couple of years the Profit Margin of CBRE has declined.
  • CBRE's Operating Margin of 3.19% is in line compared to the rest of the industry. CBRE outperforms 59.68% of its industry peers.
  • CBRE's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 18.66%, CBRE is in line with its industry, outperforming 43.55% of the companies in the same industry.
  • CBRE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.19%
PM (TTM) 2.85%
GM 18.66%
OM growth 3Y-9.5%
OM growth 5Y-5.5%
PM growth 3Y-14.49%
PM growth 5Y-2%
GM growth 3Y-3.73%
GM growth 5Y-1.09%
CBRE Yearly Profit, Operating, Gross MarginsCBRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CBRE Health Analysis

2.1 Basic Checks

  • CBRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, CBRE has less shares outstanding
  • Compared to 5 years ago, CBRE has less shares outstanding
  • The debt/assets ratio for CBRE is higher compared to a year ago.
CBRE Yearly Shares OutstandingCBRE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CBRE Yearly Total Debt VS Total AssetsCBRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • CBRE has an Altman-Z score of 3.08. This indicates that CBRE is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.08, CBRE is in the better half of the industry, outperforming 74.19% of the companies in the same industry.
  • The Debt to FCF ratio of CBRE is 6.56, which is on the high side as it means it would take CBRE, 6.56 years of fcf income to pay off all of its debts.
  • CBRE's Debt to FCF ratio of 6.56 is fine compared to the rest of the industry. CBRE outperforms 66.13% of its industry peers.
  • A Debt/Equity ratio of 0.87 indicates that CBRE is somewhat dependend on debt financing.
  • CBRE has a Debt to Equity ratio (0.87) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 6.56
Altman-Z 3.08
ROIC/WACC0.59
WACC8.65%
CBRE Yearly LT Debt VS Equity VS FCFCBRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.09 indicates that CBRE should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.09, CBRE is not doing good in the industry: 70.97% of the companies in the same industry are doing better.
  • CBRE has a Quick Ratio of 1.09. This is a normal value and indicates that CBRE is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.09, CBRE is not doing good in the industry: 67.74% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
CBRE Yearly Current Assets VS Current LiabilitesCBRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. CBRE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 37.57% over the past year.
  • The Earnings Per Share has been growing by 14.27% on average over the past years. This is quite good.
  • The Revenue has grown by 13.37% in the past year. This is quite good.
  • Measured over the past years, CBRE shows a quite strong growth in Revenue. The Revenue has been growing by 11.22% on average per year.
EPS 1Y (TTM)37.57%
EPS 3Y4%
EPS 5Y14.27%
EPS Q2Q%87.21%
Revenue 1Y (TTM)13.37%
Revenue growth 3Y9.57%
Revenue growth 5Y11.22%
Sales Q2Q%18.15%

3.2 Future

  • CBRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.93% yearly.
  • Based on estimates for the next years, CBRE will show a quite strong growth in Revenue. The Revenue will grow by 8.82% on average per year.
EPS Next Y19.08%
EPS Next 2Y17.68%
EPS Next 3Y16.12%
EPS Next 5Y15.93%
Revenue Next Year11.64%
Revenue Next 2Y10.34%
Revenue Next 3Y9.91%
Revenue Next 5Y8.82%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CBRE Yearly Revenue VS EstimatesCBRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
CBRE Yearly EPS VS EstimatesCBRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. CBRE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 19.86 indicates a rather expensive valuation of CBRE.
  • Based on the Price/Earnings ratio, CBRE is valued a bit cheaper than the industry average as 74.19% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.64. CBRE is valued slightly cheaper when compared to this.
  • The Price/Forward Earnings ratio is 16.03, which indicates a correct valuation of CBRE.
  • Based on the Price/Forward Earnings ratio, CBRE is valued cheaper than 85.48% of the companies in the same industry.
  • CBRE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.36.
Industry RankSector Rank
PE 19.86
Fwd PE 16.03
CBRE Price Earnings VS Forward Price EarningsCBRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CBRE is valued a bit cheaper than 70.97% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CBRE is valued a bit cheaper than the industry average as 70.97% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 34.85
EV/EBITDA 20.29
CBRE Per share dataCBRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of CBRE may justify a higher PE ratio.
  • A more expensive valuation may be justified as CBRE's earnings are expected to grow with 16.12% in the coming years.
PEG (NY)1.04
PEG (5Y)1.39
EPS Next 2Y17.68%
EPS Next 3Y16.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CBRE Dividend Analysis

5.1 Amount

  • No dividends for CBRE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CBRE Fundamentals: All Metrics, Ratios and Statistics

CBRE GROUP INC - A

NYSE:CBRE (5/1/2026, 8:13:50 PM)

After market: 141.81 0 (0%)

141.81

-0.92 (-0.64%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Industry Strength5.59
Industry Growth80.12
Earnings (Last)04-23
Earnings (Next)07-27
Inst Owners99.1%
Inst Owner Change1.05%
Ins Owners0.6%
Ins Owner Change4.48%
Market Cap41.57B
Revenue(TTM)40.55B
Net Income(TTM)1.16B
Analysts83
Price Target184.48 (30.09%)
Short Float %1.23%
Short Ratio1.52
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.98%
Min EPS beat(2)0.04%
Max EPS beat(2)7.92%
EPS beat(4)4
Avg EPS beat(4)6.74%
Min EPS beat(4)0.04%
Max EPS beat(4)10.42%
EPS beat(8)8
Avg EPS beat(8)7.13%
EPS beat(12)12
Avg EPS beat(12)7.3%
EPS beat(16)15
Avg EPS beat(16)8.79%
Revenue beat(2)0
Avg Revenue beat(2)-1.69%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)-0.77%
Revenue beat(4)1
Avg Revenue beat(4)-1.05%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)1.13%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)7
Avg Revenue beat(16)-0.24%
PT rev (1m)-0.78%
PT rev (3m)-3.48%
EPS NQ rev (1m)0.36%
EPS NQ rev (3m)7.19%
EPS NY rev (1m)0.33%
EPS NY rev (3m)1.26%
Revenue NQ rev (1m)-0.33%
Revenue NQ rev (3m)3.15%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)1.86%
Valuation
Industry RankSector Rank
PE 19.86
Fwd PE 16.03
P/S 1.03
P/FCF 34.85
P/OCF 26.66
P/B 4.68
P/tB N/A
EV/EBITDA 20.29
EPS(TTM)7.14
EY5.03%
EPS(NY)8.85
Fwd EY6.24%
FCF(TTM)4.07
FCFY2.87%
OCF(TTM)5.32
OCFY3.75%
SpS138.33
BVpS30.29
TBVpS-3.91
PEG (NY)1.04
PEG (5Y)1.39
Graham Number69.7526 (-50.81%)
Profitability
Industry RankSector Rank
ROA 3.75%
ROE 13.03%
ROCE 6.97%
ROIC 5.08%
ROICexc 5.57%
ROICexgc 11.69%
OM 3.19%
PM (TTM) 2.85%
GM 18.66%
FCFM 2.94%
ROA(3y)4.03%
ROA(5y)5.45%
ROE(3y)12.16%
ROE(5y)15.19%
ROIC(3y)6.32%
ROIC(5y)7.21%
ROICexc(3y)6.87%
ROICexc(5y)8.07%
ROICexgc(3y)14.53%
ROICexgc(5y)18.56%
ROCE(3y)8.23%
ROCE(5y)9.39%
ROICexgc growth 3Y-21.33%
ROICexgc growth 5Y-6.1%
ROICexc growth 3Y-16.05%
ROICexc growth 5Y-7%
OM growth 3Y-9.5%
OM growth 5Y-5.5%
PM growth 3Y-14.49%
PM growth 5Y-2%
GM growth 3Y-3.73%
GM growth 5Y-1.09%
F-Score5
Asset Turnover1.31
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 6.56
Debt/EBITDA 3.46
Cap/Depr 39.44%
Cap/Sales 0.9%
Interest Coverage 2.89
Cash Conversion 70.19%
Profit Quality 103.11%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 3.08
F-Score5
WACC8.65%
ROIC/WACC0.59
Cap/Depr(3y)44.67%
Cap/Depr(5y)43.27%
Cap/Sales(3y)0.91%
Cap/Sales(5y)0.86%
Profit Quality(3y)88.53%
Profit Quality(5y)96.03%
High Growth Momentum
Growth
EPS 1Y (TTM)37.57%
EPS 3Y4%
EPS 5Y14.27%
EPS Q2Q%87.21%
EPS Next Y19.08%
EPS Next 2Y17.68%
EPS Next 3Y16.12%
EPS Next 5Y15.93%
Revenue 1Y (TTM)13.37%
Revenue growth 3Y9.57%
Revenue growth 5Y11.22%
Sales Q2Q%18.15%
Revenue Next Year11.64%
Revenue Next 2Y10.34%
Revenue Next 3Y9.91%
Revenue Next 5Y8.82%
EBIT growth 1Y-15.16%
EBIT growth 3Y-0.84%
EBIT growth 5Y5.11%
EBIT Next Year50.39%
EBIT Next 3Y22.85%
EBIT Next 5Y16.26%
FCF growth 1Y-14.85%
FCF growth 3Y-4.48%
FCF growth 5Y-5.27%
OCF growth 1Y-8.72%
OCF growth 3Y-1.46%
OCF growth 5Y-3.16%

CBRE GROUP INC - A / CBRE Fundamental Analysis FAQ

What is the fundamental rating for CBRE stock?

ChartMill assigns a fundamental rating of 5 / 10 to CBRE.


What is the valuation status for CBRE stock?

ChartMill assigns a valuation rating of 6 / 10 to CBRE GROUP INC - A (CBRE). This can be considered as Fairly Valued.


How profitable is CBRE GROUP INC - A (CBRE) stock?

CBRE GROUP INC - A (CBRE) has a profitability rating of 6 / 10.


What is the financial health of CBRE GROUP INC - A (CBRE) stock?

The financial health rating of CBRE GROUP INC - A (CBRE) is 5 / 10.


What is the earnings growth outlook for CBRE GROUP INC - A?

The Earnings per Share (EPS) of CBRE GROUP INC - A (CBRE) is expected to grow by 19.08% in the next year.